INTERPARFUMS INC IPAR
Nasdaq · stock · Perfumes, Cosmetics & Other Toilet Preparations · website · IPO 1984-09-16
INTERPARFUMS INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.5B | $1.3B | $1.1B | $879.5M | $539.0M | $713.5M | $675.6M | $591.3M | $521.1M |
| Gross profit | $947.2M | $927.3M | $839.1M | $694.4M | $556.9M | $330.7M | $445.9M | $427.6M | $376.3M | $326.5M |
| SG&A expense | $676.9M | $648.5M | $587.7M | $492.4M | $406.5M | $260.6M | $341.2M | $332.8M | $295.5M | $258.8M |
| Operating income | $270.3M | $274.8M | $251.4M | $194.3M | $148.1M | $70.1M | $104.7M | $94.7M | $78.6M | $66.7M |
| Interest expense | — | — | $11.3M | $3.6M | $2.8M | $2.0M | $2.1M | $2.6M | $2.0M | $2.3M |
| Income tax | $63.2M | $65.0M | $61.8M | $43.2M | $41.0M | $19.4M | $29.1M | $26.1M | $22.8M | $23.8M |
| Net income | $168.4M | $164.4M | $152.7M | $120.9M | $87.4M | $38.2M | $60.2M | $53.8M | $41.6M | $33.3M |
| EPS (diluted) | $5.24 | $5.12 | $4.75 | $3.78 | $2.75 | $1.21 | $1.90 | $1.71 | $1.33 | $1.07 |
| Operating cash flow | $214.9M | $187.6M | $105.8M | $73.0M | $119.6M | $65.0M | $76.5M | $63.0M | $35.9M | $54.6M |
| Free cash flow | $190.5M | $182.9M | $99.3M | $39.3M | -$21.7M | $54.0M | $71.0M | $59.1M | $32.9M | $49.8M |
| Cash & equivalents | — | — | — | $104.7M | $159.6B | $169.7M | $133.4M | $193.1M | $208.3M | $161.8M |
| Inventory | $351.4M | $371.9M | $371.9M | $290.0M | $198.9M | $158.8M | $167.8M | $161.8M | $137.1M | $97.0M |
| Total assets | $1.6B | $1.4B | $1.4B | $1.3B | $1.1B | $890.1M | $828.8M | $797.8M | $777.8M | $682.4M |
| Total liabilities | $481.2M | — | — | — | — | — | — | — | — | — |
| Shareholders' equity | $1.1B | $942.6M | $892.2M | $788.1M | $738.3M | $702.5M | $609.0M | $585.7M | $570.6M | $483.7M |
Growth · year-over-year · Revenue CAGR 12.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +2.5% | +10.2% | +21.3% | +23.6% | +63.2% | -24.5% | +5.6% | +14.3% | +13.5% | +11.2% |
| Net income growth | +2.5% | +7.7% | +26.2% | +38.4% | +128.7% | -36.6% | +12.0% | +29.3% | +24.8% | +9.5% |
| EPS growth | +2.3% | +7.8% | +25.7% | +37.5% | +127.3% | -36.3% | +11.1% | +28.6% | +24.3% | +9.2% |
| Free cash flow growth | +4.1% | +84.2% | +152.9% | — | -140.2% | -24.0% | +20.2% | +79.8% | -34.0% | +8.4% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.